PUBLICAÇÕES científicas

/cun/pt/investigacion/publicaciones-cientificas/areaMain/02
  • Flow Cytometry

    Gascue A (1), Merino J (1), Paiva B (2)

    (1) Department of immunology, Clínica Universidad de Navarra, Av. Pio XII, 36, Pamplona, 31008, Spain.
    (2) Department of immunology, Clínica Universidad de Navarra, Av. Pio XII, 36, Pamplona, 31008, Spain; Centre for Applied Medical Research (CIMA), Pamplona, Spain; Healthcare Research Institute of Navarre (IDISNA), Pamplona, Spain; CIBERONC, Spain.

    Hematology/Oncology Clinics of North America 01 de OUTUBRO de 2018

  • FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence

    Jimenez-Fonseca P (1), Carmona-Bayonas A (2), Calderon C (3), Fontcuberta Boj J (4), Font C (5), Lecumberri R (6), Monreal M (7), Muñoz Martín AJ (8), Otero R (9), Rubio A (10), Ruiz-Artacho P (11), Suarez Fernández C (12), Colome E (13), Pérez Segura P (14).
    (1) Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
    (2) Hematology and Medical Oncology Department, UMU, IMIB, Hospital Universitario Morales Meseguer, Murcia, Spain.
    (3) Clinical Psychology and Psychobiology Department, Faculty of Psychology, University of Barcelona, Barcelona, Spain.
    (4) Unitat d'Hemostàsia i Trombosi, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
    (5) Medical Oncology Department, IDIBAPS/Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Universitari Clínic, Barcelona, Spain.
    (6) Hemaotology Department, Clínica Universidad de Navarra, Pamplona, Spain.
    (7) Internal Medicine Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
    (8) Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
    (9) Medical-Surgical Unit for Respiratory Disease, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Sevilla, Spain.
    (10) Pharmacy Department, Hospital Virgen de la Salud, Toledo, Spain.
    (11) Emergency Department, Hospital Universitario Clínico San Carlos, IdISSC, Madrid, Spain.
    (12) Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain.
    (13) Scientific Affairs, LEO Pharma, Barcelona, S.A, Spain.
    (14) Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.

    Clinical&Translational Oncology 27 de FEVEREIRO de 2017

  • Follicular lymphoma (FL): immunological tolerance theory in FL

    García-Muñoz R (1), Panizo C (2). (1) Hematology Department, Hospital San Pedro, Logroño, La Rioja, Spain.
    (2) Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain. 

    Human Immunology 29 de SETEMBRO de 2016

  • FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited

    Ataseven B (1), Chiva LM (2), Harter P (1), Gonzalez-Martin A (3), du Bois A (4). (1) Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
    (2) Department of Gynecologic Oncology, MD Anderson Cancer Center, Madrid, Spain.
    (3) Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
    (4) Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.

    Gynecologic Oncology 01 de SETEMBRO de 2016

  • First -line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders

    Martínez-Calle N (1), Alfonso A (1), Rifón J (1), Herrero I (2), Errasti P (3), Rábago G (4), Merino J (5), Panizo Á (6), Pardo J (6), Prósper F (1), García-Muñoz R (7), Lecumberri R (1), Panizo C (1).
    (1) Hematology Department, Clínica Universidad de Navarra, Pamplona, España.
    (2) Hepatology Department, Clínica Universidad de Navarra, Pamplona, España.
    (3) Nephrology Department, Clínica Universidad de Navarra, Pamplona, España.
    (4) Cardiac Surgery Department, Clínica Universidad de Navarra, Pamplona, España.
    (5) Immunology Department, Clínica Universidad de Navarra, Pamplona, España.
    (6) Clinical Department of Pathology, Clínica Universidad de Navarra, Pamplona, España.
    (7) Hematology Department, Hospital san Pedro de Logroño, La Rioja, España. 

    European Journal of Haematology 27 de MAIO de 2016

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra